Literature DB >> 34231497

Optimizing Detection of Lymphatic Invasion in Primary Cutaneous Melanoma With the Use of D2-40 and a Paired Melanocytic Marker.

Richard J Straker1, Laura A Taylor2, Madalyn G Neuwirth3, Andrew J Sinnamon4, Adrienne B Shannon1, James Abbott5, John T Miura1, Emily Y Chu6, Xiaowei Xu7, Giorgos C Karakousis1.   

Abstract

ABSTRACT: Dual immunohistochemical (IHC) staining with D2-40 and S100 improves detection of lymphatic invasion (LI) in primary cutaneous melanoma. However, limited data exist evaluating this technique using other melanocytic markers, and thus, the optimal marker for detection of LI is unestablished. To address this knowledge gap, a case-control study was performed comparing melanoma specimens from 22 patients with known lymphatic spread (LS) with a control group of 11 patients without LS. Specimens underwent dual IHC staining with D2-40 and MART-1, SOX-10, and S100 to evaluate for LI. Receiver operating characteristic analysis was used to estimate each stain's accuracy for detection of LI. The LS group was more likely to be ≥65 years (P = 0.04), have a tumor thickness of ≥1 mm (P < 0.01), and have ulcerated tumors (P = 0.02). Detection of LI with D2-40/MART-1 significantly correlated with LS (P = 0.03), and the D2-40/MART-1 stain was most accurate for LI based on receiver operating characteristic curve analysis (area under the curve [AUC] 0.705) in comparison with D2-40/SOX-10 (AUC 0.575) and D2-40/S100 (AUC 0.633). These findings suggest that MART-1 may be the optimal melanocytic marker to combine with D2-40 for detection of LI in melanoma. Further studies are needed to determine the utility of routinely performing these stains for histopathologic analysis of melanoma.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34231497      PMCID: PMC8671172          DOI: 10.1097/DAD.0000000000002018

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.319


  29 in total

1.  Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?

Authors:  Darius J Karimipour; Lori Lowe; Lyndon Su; Ted Hamilton; Vernon Sondak; Timothy M Johnson; Douglas Fullen
Journal:  J Am Acad Dermatol       Date:  2004-05       Impact factor: 11.527

2.  Lymphovascular invasion as a prognostic factor in melanoma.

Authors:  Michael E Egger; Julianna E Gilbert; Alison L Burton; Kelly M McMasters; Glenda G Callender; Amy R Quillo; Russell E Brown; Charles R St Hill; Lee Hagendoorn; Robert C G Martin; Arnold J Stromberg; Charles R Scoggins
Journal:  Am Surg       Date:  2011-08       Impact factor: 0.688

3.  Loss of S100 antigenicity in metastatic melanoma.

Authors:  Dara L Aisner; Ajay Maker; Steven A Rosenberg; David M Berman
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

Review 4.  Melanoma staging: where are we now?

Authors:  Adriano Piris; Alice Coelho Lobo; Lyn M Duncan
Journal:  Dermatol Clin       Date:  2012-07-31       Impact factor: 3.478

5.  Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma.

Authors:  Xiaowei Xu; Lianjun Chen; DuPont Guerry; Peter R Dawson; Wei-ting Hwang; Patricia VanBelle; David E Elder; Paul J Zhang; Michael E Ming; Lynn Schuchter; Phyllis A Gimotty
Journal:  Clin Cancer Res       Date:  2011-11-17       Impact factor: 12.531

6.  Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.

Authors:  Jeonghyun Shin; Jeremy G Vincent; Jonathan D Cuda; Haiyang Xu; Sewon Kang; Jinah Kim; Janis M Taube
Journal:  J Am Acad Dermatol       Date:  2012-02-09       Impact factor: 11.527

Review 7.  Tumor lymphangiogenesis and melanoma metastasis.

Authors:  Matthias Rinderknecht; Michael Detmar
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

8.  HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.

Authors:  Judit Zubovits; Elizabeth Buzney; Lawrence Yu; Lyn M Duncan
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

9.  Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis.

Authors:  Katie Doeden; Zhihai Ma; Balasubramanian Narasimhan; Susan M Swetter; Michael Detmar; Soheil S Dadras
Journal:  J Cutan Pathol       Date:  2008-11-05       Impact factor: 1.587

10.  LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.

Authors:  S Banerji; J Ni; S X Wang; S Clasper; J Su; R Tammi; M Jones; D G Jackson
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

View more
  1 in total

Review 1.  Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis.

Authors:  Costantino Ricci; Emi Dika; Francesca Ambrosi; Martina Lambertini; Giulia Veronesi; Corti Barbara
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.